Results 131 to 140 of about 5,749 (154)

Evaluating hepatocellular carcinoma (HCC) surveillance through an early diagnostic centre: An implementation science approach at a tertiary hepatology centre in England. [PDF]

Clin Med (Lond)
Farooq HZ, Galono K, Reid L, Dearden J, Foster GR.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients

Clinical Gastroenterology and Hepatology, 2023
The changes in liver stiffness measurement (LSM) are unreliable to estimate regression of fibrosis during antiviral treatment for chronic hepatitis B (CHB) patients. The age-male-albumin-bilirubin-platelets score (aMAP), as an accurate hepatocellular carcinoma risk score, may reflect the liver fibrosis stage.
Rong, Fan, Guanlin, Li, Ning, Yu, Xiujuan, Chang, Tamoore, Arshad, Wen-Yue, Liu, Yan, Chen, Grace Lai-Hung, Wong, Yiyue, Jiang, Xieer, Liang, Yongpeng, Chen, Xiao-Zhi, Jin, Zheng, Dong, Howard Ho-Wai, Leung, Xiao-Dong, Wang, Zhen, Zeng, Terry Cheuk-Fung, Yip, Qing, Xie, Deming, Tan, Shaoli, You, Dong, Ji, Jun, Zhao, Arun J, Sanyal, Jian, Sun, Ming-Hua, Zheng, Vincent Wai-Sun, Wong, Yongping, Yang, Jinlin, Hou   +27 more
openaire   +4 more sources

aMAP score prediction of hepatocellular carcinoma occurrence and incidence‐free rate after a sustained virologic response in chronic hepatitis C

Hepatology Research, 2021
AbstractAimsHepatocellular carcinoma (HCC) can still occur in hepatitis C virus (HCV) patients who have achieved a sustained virologic response (SVR), which remains an important clinical issue in the direct‐acting antivirals era. The current study investigated the clinical utility of the aMAP score (consisting of age, male, albumin–bilirubin, and ...
Yuki Yamashita, Satoru Joshita, Ayumi Sugiura, Tomoo Yamazaki, Hiroyuki Kobayashi, Shun‐ichi Wakabayashi, Yosuke Yamada, Soichiro Shibata, Hideo Kunimoto, Takanobu Iwadare, Makiko Matsumura, Chiharu Miyabayashi, Taiki Okumura, Sachie Ozawa, Yuichi Nozawa, Natsuko Kobayashi, Michiharu Komatsu, Naoyuki Fujimori, Hiromi Saito, Takeji Umemura   +19 more
openaire   +4 more sources

The aMAP score predicts long-term outcomes after resection of hepatocellular carcinoma: a multi-institutional analysis

HPB
The aMAP score is a proposed model to predict the development of hepatocellular carcinoma (HCC) among high-risk patients with chronic hepatitis. The role of the aMAP score to predict long-term survival among patients following resection of HCC has not been determined.Patients undergoing resection for HCC between 2000 and 2020 were identified using a ...
Diamantis I. Tsilimigras, Yutaka Endo, Francesca Ratti, Hugo P. Marques, François Cauchy, Vincent Lam, George A. Poultsides, Irinel Popescu, Sorin Alexandrescu, Guillaume Martel, Minoru Kitago, Alfredo Guglielmi, Tom Hugh, Luca Aldrighetti, Ana Gleisner, Feng Shen, Itaru Endo, Timothy M. Pawlik   +17 more
openaire   +4 more sources

[Predictive value of aMAP risk score for early recurrence of small hepatocellular carcinoma after microwave ablation].

Zhonghua nei ke za zhi, 2023
Objective: To explore the value of the aMAP risk score (age, male, albumin-bilirubin, and platelets) to predict early recurrence within one year after microwave ablation in patients with small hepatocellular carcinoma. Methods: This was a retrospective study that enrolled 142 patients diagnosed with hepatocellular carcinoma who were treated with ...
S Y, Dong, S Y, Deng, R, Fan, J Z, Chen, X, Cheng, X, Hao, W C, Dai   +6 more
openaire   +1 more source

P70 HCC surveillance in a nurse-led clinic: assessing adherence to guidelines and possible role of aMAP score

Poster presentations, 2022
Mohamed Elnagar, Muhammad Saleem, Alison Beard, Samantha Whyld, Andrew Austin   +4 more
openaire   +1 more source

aMAP score and its combination with liver stiffness measurement accurately assess liver fibrosis in virologically suppressed CHB patients

Journal of Hepatology, 2023
Rong Fan, Guanlin Li, Ning Yu, Xiu-Juan Chang, Tamoore Arshad, Wen-Yue Liu, Yan Chen, Grace Lai-Hung Wong, Yiyue Jiang, Xieer Liang, Yongpeng Chen, Xiao-Zhi Jin, Zheng Dong, Howard Ho-Wai Leung, Xiaodong Wang, Zhen Zeng, Terry Cheuk-Fung Yip, Qing Xie, Deming Tan, Shaoli You, Dong Ji, Jun Zhao, Arun Sanyal, Jian Sun, Ming-Hua Zheng, Vincent Wai-Sun Wong, Yongping Yang, Jinlin Hou   +27 more
openaire   +1 more source

Sa1602 THE UTILITY OF AMAP SCORE IN PREDICTING HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH ADVANCED NON-ALCOHOLIC FATTY LIVER DISEASE

Gastroenterology, 2023
Chinmay Bera, Heather M. Kosick, Mohamed Shengir, Oyedele Adeyi, Giada Sebastiani, Keyur Patel   +5 more
openaire   +1 more source

Baseline cirrhosis in addition to the aMAP score, increased the risk of developing hepatocellular carcinoma in patients with hepatitis B

Journal of Hepatology, 2023
Supakorn Chaiwiriyawong, Pimsiri Sripongpun, Naichaya Chamroonkul, Apichat Kaewdech   +3 more
openaire   +1 more source